{"text": "Tumor Suppressor <extra_id_0> WWOX <extra_id_2> Protein <extra_id_1> and <extra_id_0> p53 <extra_id_2> Protein <extra_id_1> Alterations and Drug Resistance in Glioblastomas", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Tumor suppressor <extra_id_0> p53 <extra_id_2> Protein <extra_id_1> are frequently mutated in glioblastomas ( GBMs ) and appears to contribute , in part , to resistance to temozolomide ( TMZ ) and therapeutic drugs .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "<extra_id_0> WW domain-containing oxidoreductase <extra_id_2> Protein <extra_id_1> <extra_id_0> WWOX <extra_id_2> Protein <extra_id_1> ( <extra_id_0> FOR <extra_id_2> Protein <extra_id_1> or <extra_id_0> WOX1 <extra_id_2> Protein <extra_id_1> ) is a proapoptotic protein and is considered as a tumor suppressor .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Loss of <extra_id_0> WWOX <extra_id_2> Protein <extra_id_1> gene expression is frequently seen in malignant cancer cells due to promoter hypermethylation , genetic alterations , and translational blockade .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Intriguingly , ectopic expression of wild type <extra_id_0> WWOX <extra_id_2> Protein <extra_id_1> preferentially induces apoptosis in human glioblastoma cells harboring mutant <extra_id_0> p53 <extra_id_2> Protein <extra_id_1> .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "<extra_id_0> WWOX <extra_id_2> Protein <extra_id_1> is known to physically bind and stabilize wild type <extra_id_0> p53 <extra_id_2> Protein <extra_id_1> .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Here , we provide an overview for the updated knowledge in <extra_id_0> p53 <extra_id_2> Protein <extra_id_1> and <extra_id_0> WWOX <extra_id_2> Protein <extra_id_1> , and postulate potential scenarios that wild type and mutant <extra_id_0> p53 <extra_id_2> Protein <extra_id_1> , or isoforms , modulate the apoptotic function of <extra_id_0> WWOX <extra_id_2> Protein <extra_id_1> .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "We propose that triggering <extra_id_0> WWOX <extra_id_2> Protein <extra_id_1> activation by therapeutic drugs under <extra_id_0> p53 <extra_id_2> Protein <extra_id_1> functional deficiency is needed to overcome TMZ resistance and induce GBM cell death .", "event": "<extra_id_0> <extra_id_1>"}
